In comparison, BRAF p.V600E occurs in over 50% of adult papillary thyroid carcinoma (PTC) and NRAS/HRAS/KRAS mutations in 30-45% of follicular thyroid cancer and follicular variant PTC (23, 24). This evidence concerns the gene NRAS and thyroid gland papillary carcinoma.